The Vanderbilt Institute for Clinical and Translational Research (VICTR) and RTI International, a non-profit clinical research organization based in North Carolina, have been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.
VICTR provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC).
Supported by a one-year, $2.1-million federal grant, the ACC will ensure the efficient and effective operation of a COVID-19 Clinical Trials Platform developed by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).